Washington Biotechnology
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
    • Rheumatoid Arthritis
      • Collagen-Induced Arthritis Model
      • Adjuvant-Induced Arthritis Model
      • Carrageenan Air Pouch Model
      • Zymosan Air Pouch Model
      • Pristane-Induced Arthritis Model
      • Ovalbumin-Induced Arthritis Model
      • SCW PG-PS 10S Rat Model
      • Arthritis Combo Testing: Rodent/Rabbit
    • Cancer
      • WBI Cell Lines for Cancer Models
      • Xenograft, Orthotopic & Syngeneic Models
    • Bacterial Infection
      • MRSA Model
      • Listeria Model
    • Pain Studies
      • Formalin Test (Chemical Sensitivity)
    • Pharmacokinetics and Toxicity
      • Pharmacokinetics (PK)
      • Toxicity and MTD Studies
    • Support Services
      • In Vitro Compound Screening for Anti-inflammatory Activity
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers
  • In Vivo CRO Services
    • Autoimmune & Inflammatory Diseases
      • Multiple Sclerosis
      • Gout
      • Inflammatory Bowel Disease (IBD)
      • Dermatitis (Contact)
      • Lupus
        • SLE Mouse Model
      • Nephritis
      • Pancreatitis
      • Hepatitis
      • Psoriasis
      • Pulmonary Fibrosis
      • Diabetes
      • General Inflammation Assessment
    • Rheumatoid Arthritis
    • Cancer
    • Bacterial Infection
    • Pain Studies
    • Pharmacokinetics and Toxicity
    • Support Services
    • WBI Project Management
  • About Us
  • What's New
  • Contact Us
  • Sitemap
  • Careers

SLE Mouse Model

 

Mouse models have contributed to significant progress in uncovering mechanisms by which lupus develops and sustains disease conditions and in evaluations of therapeutic efficacy. Pristane-induced lupus is a well-established model of murine lupus. Disease development following injection of pristane in a variety of mouse strains leads to an inflammatory process resulting in lupus-specific autoantibodies, immune complex deposition resulting in a variety of organ manifestations with a high prevalence of nephritis.

The purpose of this in vivo study is to provide information for development of human therapeutic products for treatment of  lupus disease. There is no in vitro model available to develop the information. An animal model is very popular for the study of lupus to obtain the systemic information with the characteristics of the human SLE.

The animal model selected and the animal species is based on studies in the scientific literature indicating the usefulness of this model for development of drugs for treatment of human disease.

 

SLE Mouse Model
A well-established model of murine lupus
Species

Balb/c mice, 7-9 week old, female

Group Size 10
Study Duration 3-6 months
Read-outs

Observations and body weight once a week, Anti-dsDNA, ANA (titer and photos), Serum Cytokines (TNF a, IL-beta, IL-17)

Optional

Kidney tissue histopathology (the severity of the renal lesion)

Glomerulonephritis, renal tubular lesions and interstitial inflammation observed

Immunohistochemistry: IgG and complement C3c in the glomeruli

anti-snRNP/Sm (small nuclear ribonucleoproteins)

Anti-chromatin autoantibody

Histone Antibodies

Other Cytokines as requested

 

 

Comparison of autoantibody (anti-ds DNA lgG) with PBS (group 1), pristane/vehicle (group 2), prednisone (group 3) and test compound (group 4) treatment

​

 

Antinuclear antibodies in the sera of control (PBS), pristane-treated, prednisone and test compound treatment mice at week 12 (top) and week 20 (below) after pristane injection were determined by immunofluorescence staining on HEp-2 cells (IFA photos, 1:40 serum dilution)

 

WEEK 12

 

WEEK 20

Contact Us
Request a Quote
What's New?
Read Our Newsletter

© Washington Biotechnology Inc., 2014. All Rights Reserved.
Built by Biz-Zone